Materias dentro de su búsqueda.
Mostrando 76,541 - 76,560 Resultados de 77,247 Para Buscar '"Junee"', tiempo de consulta: 0.52s Limitar resultados
  1. 76541
    “…Presentation: Monday, June 13, 2022 12:30 p.m. - 2:30 p.m.…”
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    PMON73 Lipid profile in patients with Cushing's syndrome and the impact of surgical treatment
  2. 76542
    “…Presentation: Saturday, June 11, 2022 12:30 p.m. - 12:45 p.m.…”
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    OR09-5 mTOR Signaling is Associated with Regulation of Mitochondrial Respiration in Thyroid Cancer
  3. 76543
    “…Presentation: Saturday, June 11, 2022 1:00 p.m. - 3:00 p.m.…”
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    PSAT219 Renal Phosphate Wasting Caused by ENPP-1 mutation.
  4. 76544
    “…Presentation: Saturday, June 11, 2022 1:00 p.m. - 3:00 p.m.…”
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    PSAT387 An Unusual Case of Sporadic Metastatic Medullary Thyroid Cancer Without a Primary Tumor Presenting with Paraneoplastic Cushing's Syndrome
  5. 76545
    “…Presentation: Saturday, June 11, 2022 1:00 p.m. - 3:00 p.m.…”
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    LBSAT144 Single-center Experience With Hyperparathyroidism-jaw Tumor Syndrome - Where Do We Stand?
  6. 76546
    “…In conclusion, MS-Hu6 is efficacious, durable and manufacturable, and is therefore poised for future human testing as a multipurpose therapeutic for obesity, osteoporosis, and perhaps for AD.References: (1)Sun et al., Cell, 2006, PMID: 16630814; Ji et al, PNAS, 2018, PMID: 29440419; (3)Liu et al., Nature, 2017, PMID: 28538730; (4)Xiong et al., Nature (In press); (5)Gera et al., PNAS, 2020, PMID: 33127753 Presentation: Monday, June 13, 2022 12:30 p.m. - 2:30 p.m.…”
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    PMON51 A Single Multipurpose FSH–Blocking Therapeutic for Osteoporosis, Obesity and Alzheimer's Disease
  7. 76547
    “…Presentation: Saturday, June 11, 2022 1:00 p.m. - 3:00 p.m.…”
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    PSAT385 Single Center Experience with the Combination of Lenvatinib and Pembrolizumab for the Treatment of Anaplastic Thyroid Cancer
  8. 76548
    “…Presentation: Tuesday, June 14, 2022 10:45 a.m. - 11:00 a.m.…”
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    OR30-5 Androgen-Regulated Secreted Factors Promote Tumorigenesis and Immune Suppression in Breast Cancer
  9. 76549
    “…Presentation: Sunday, June 12, 2022 12:00 p.m. - 12:15 p.m.…”
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    OR13-5 Bone Morphogenetic Protein-4 (BMP4) Inhibits Adrenal Cell Cortisol Synthesis by Blocking CYP17A1 and CYP11B1 Expression.
  10. 76550
    “…Presentation: Saturday, June 11, 2022 11:30 a.m. - 11:45 a.m.…”
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    OR01-1 Proximal Femur Fracture Incidence by Sex among Older US Asian/Pacific Islander Adults and non-Hispanic White Adults
  11. 76551
    “…Presentation: Saturday, June 11, 2022 1:00 p.m. - 3:00 p.m.…”
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    PSAT382 Characterization of Ultrasound and Cytological Features Identifying Thyroid Nodules with Aggressive Behavior: From Histology to Clinic
  12. 76552
    “…Presentation: Saturday, June 11, 2022 1:00 p.m. - 3:00 p.m.…”
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    PSAT215 Hypercalcemic Crisis Complicating a First Trimester Pregnancy Caused by a Giant Parathyroid Adenoma Masquerading as a Thyroid Nodule
  13. 76553
    “…Presentation: Sunday, June 12, 2022 12:30 p.m. - 2:30 p.m.…”
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    LBSUN319 Characteristics And Treatment Patterns Of Hispanic/latino Patients Initiating First Injectable Glp-1ra Or Basal Insulin
  14. 76554
    “…FINDINGS: Between Sept 20, 2016, and June 28, 2021, 37 children with HIV-associated TB (median age 11·9 years [range 0·4–17·6], 19 [51%] were female and 18 [49%] were male, 36 [97%] in Africa and one [3%] in Thailand) received rifampicin with twice-daily dolutegravir and were included in the safety analysis. 20 (54%) of 37 children enrolled in the pharmacokinetic substudy, 14 of whom contributed at least one evaluable pharmacokinetic curve for dolutegravir, including 12 who had within-participant comparisons. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Dolutegravir twice-daily dosing in children with HIV-associated tuberculosis: a pharmacokinetic and safety study within the open-label, multicentre, randomised, non-inferiority ODYSSEY trial
  15. 76555
    “…Data were analyzed from August 2020 through June 2022. MAIN OUTCOMES AND MEASURES: The primary outcome was the year when rates of prostate cancer incidence changed directionality by age and race and ethnicity. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Variations in Age-Adjusted Prostate Cancer Incidence Rates by Race and Ethnicity After Changes in Prostate-Specific Antigen Screening Recommendation
  16. 76556
    “…METHODS: We conducted a retrospective cohort study evaluating patients who were hospitalized for ≥ 1 day with discharge or death between June 1, 2019, and September 4, 2021, across 271 US health care facilities. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Epidemiology and outcomes of culture-positive bloodstream pathogens prior to and during the SARS-CoV-2 pandemic: a multicenter evaluation
  17. 76557
    “…METHODS: A total of 24,349 newborns from Jiangxi Maternal and Child Health Hospital were enrolled in our study from April 2021 to June 2022. Newborn hearing screening was conducted using otoacoustic emission (OAE) and automated auditory brainstem response (AABR). …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Concurrent newborn hearing and genetic screening of common hearing loss variants with bloodspot-based targeted next generation sequencing in Jiangxi province
  18. 76558
    “…A total of 2 039 854 individuals who received any dose of a COVID-19 vaccine with emergency use authorization (BNT162b2 [Pfizer-BioNTech], mRNA-1273 [Moderna], or Ad26.COV2.S [Johnson & Johnson]) from December 11, 2020, through June 30, 2021, were eligible for inclusion. Individuals included in the SCRI analysis were a subset of the COVID-19–vaccinated cohort who had herpes zoster during either a risk or control interval. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Assessment of Herpes Zoster Risk Among Recipients of COVID-19 Vaccine
  19. 76559
    “…Data were analyzed between June 17, 2021, and August 6, 2021. INTERVENTIONS: All patients in phases 1b and 2 received avelumab plus talazoparib. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Avelumab Plus Talazoparib in Patients With Advanced Solid Tumors: The JAVELIN PARP Medley Nonrandomized Controlled Trial
  20. 76560
    “…Method This prospective cohort study was conducted on newly diagnosed advanced NSCLC patients between June 2020 and April 2021. These patients were given platinum-based doublet chemotherapy guided by histology and targeted therapy based on molecular studies. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Impact of Comorbidity Scores on the Overall Survival of Patients With Advanced Non-small Cell Lung Cancer: A Real-World Experience From Eastern India
Herramientas de búsqueda: RSS